Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

12/11 Earnings release - Q3 2026

More about the company

Quotes

Date	Price	Change	Volume
14/26/14	NOK 0.2860	+1.06%	5,63,471
11/26/11	NOK 0.2830	+0.53%	13,23,158
10/26/10	NOK 0.2815	-1.23%	10,49,070
09/26/09	NOK 0.2850	-1.72%	3,46,900
08/26/08	NOK 0.2900	+3.02%	12,41,485

Real-time Oslo Bors

More quotes

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

Real-time Oslo Bors 04:05:41 14/09/2026 pm IST			5-day change	1st Jan Change
0.2860 ^NOK	+1.06%		+1.60%	-91.23%

10:39am	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
11/09	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI

Market Cap	12Cr 1.24Cr 1.07Cr 1.01Cr 91.87L 1.72Cr 118.7Cr 1.73Cr 12Cr 4.63Cr 60Cr 4.67Cr 4.56Cr 190.82Cr	P/E 2026 *	-0.81x	P/E 2027 *	-1.77x
Enterprise Value	11Cr 1.15Cr 98.7L 93.45L 84.71L 1.59Cr 109.44Cr 1.6Cr 11Cr 4.27Cr 56Cr 4.3Cr 4.21Cr 175.93Cr	EV / Sales 2026 *	106x	EV / Sales 2027 *	-
Free-Float	65.56%	Yield 2026 *	-	Yield 2027 *	-

Markets		Quality
Oslo Bors	LIFE	Real-time
CBOE		Real-time
Nasdaq Stockholm	LIFE O	Delayed
Deutsche Boerse AG	LFC0	Delayed
Boerse Muenchen	LFC0	Real-time
Börse Stuttgart	LFC0	Delayed
CBOE		Real-time

10:39am	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
11/09	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI
31/08	Ocean GeoLoop Subsidiary to Sell Ocean Tunicell Stake to Lifecare	MT
19/08	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
19/08	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026
02/07	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
29/06	Lifecare Transfers Operations from Germany to Norway, UK	MT
27/06	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
19/06	An undisclosed buyer signed a non-binding agreement to acquire Ocean Tunicell AS from Ocean GeoLoop AS (OB:OCEAN).	CI
10/06	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
15/05	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
15/05	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
15/05	Lifecare Q1 operating loss NOK 31.5 mln	RE

Lifecare ASA Share Price

Stocks

LIFE

NO0013355859

Biotechnology & Medical Research

Valuation: Lifecare ASA

Chart: Lifecare ASA

Latest news: Lifecare ASA

Last Transcript: Lifecare ASA

Analysts' recommendations: Lifecare ASA

Press Releases: Lifecare ASA

News in other languages: Lifecare ASA

Quotes and Performance

Price Extremes

Managers and Directors: Lifecare ASA

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

19/08	Lifecare : Interim Report Q2 2026 Presentation	PU
19/08	LIFE: Lifecare ASA Q2 2026 results	PU
12/08	Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST	AQ
02/07	LIFE: Update on production transfer and longevity programme	AQ
26/06	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU

1 day	+1.06%
1 week	+1.60%
Current month	-1.21%
1 month	-10.06%
3 months	-7.74%
6 months	-29.21%
Current year	-91.23%

1 week	0.28	0.29
1 month	0.28	0.36
Current year	0.27	1.99
1 year	0.27	11.25
3 years	0.27	82.16
5 years	0.27	82.16
10 years	0.27	117

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	07/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	01/04/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	01/03/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	26/06/2020
Morten Foros Krohnstad CHM	Chairman	-	08/05/2021
Lutz Heinemann BRD	Director/Board Member	-	20/11/2020

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE ASA	+1.06%	+1.60%	-96.83%	-98.66%	1.24Cr
LONZA GROUP AG	+1.68%	-3.53%	-1.17%	+10.53%	4.55TCr
REVOLUTION MEDICINES, INC.	+0.21%	-2.98%	+337.74%	+520.30%	4.37TCr
IQVIA HOLDINGS INC.	+1.74%	-2.24%	+39.82%	+20.85%	4.31TCr
BEONE MEDICINES AG	+1.38%	-3.28%	+6.84%	+73.19%	3.94TCr
CELLTRION, INC.	-1.44%	-5.26%	+8.97%	+39.76%	3.19TCr
ASCENDIS PHARMA A/S	+0.87%	-2.60%	-	-	1.73TCr
MEDPACE HOLDINGS, INC.	+0.75%	-0.64%	+19.75%	+108.58%	1.64TCr
EUROFINS SCIENTIFIC SE	+2.74%	+1.48%	+15.19%	+31.82%	1.42TCr
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+1.93%	-3.55%	+82.00%	+36.66%	1.33TCr
Average	+1.10%	-2.97%	+45.81%	+82.56%	2.65TCr
Weighted average by Cap.	+0.99%	-3.50%	+75.15%	+125.15%

	2026 *	2027 *
Net sales	10L 1L 92.78T 87.85T 79.62T 1L 1.03Cr 2L 10.43L 4L 52.34L 4L 4L 1.65Cr	-
Net income	-11Cr -1.17Cr -1.01Cr -95.75L -86.79L -1.63Cr -112.13Cr -1.64Cr -11Cr -4.37Cr -57Cr -4.41Cr -4.31Cr -180.26Cr	-6.7Cr -72.15L -62.16L -58.86L -53.35L -1Cr -69Cr -1.01Cr -6.99Cr -2.69Cr -35Cr -2.71Cr -2.65Cr -110.8Cr
Net Debt	-90L -10L -8L -8L -7L -13.44L -9.26Cr -13.51L -93.9L -36.11L -4.71Cr -36.4L -35.6L -15Cr	40L 4L 4L 4L 3L 6L 4.11Cr 6L 41.73L 16.05L 2.09Cr 16.18L 15.82L 6.62Cr